Financial Performance - The company's operating revenue for the first half of 2021 reached ¥130,236,941.28, representing a 42.40% increase compared to ¥91,455,781.98 in the same period last year[19] - The net profit attributable to shareholders of the listed company was ¥41,290,260.17, a 70.69% increase from ¥24,189,528.19 in the previous year[19] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥39,791,342.05, reflecting a 75.19% increase from ¥22,713,561.11 year-on-year[19] - Basic earnings per share were 0.41 yuan, reflecting a 28.13% increase from 0.32 yuan in the same period last year[20] - The weighted average return on equity decreased to 5.08%, down 1.67 percentage points from 6.75% in the previous year[20] - The company achieved operating revenue of 130.24 million yuan in the reporting period, representing a 42.40% increase compared to the same period last year[20] - Net profit attributable to shareholders reached 41.29 million yuan, a growth of 70.69% year-on-year, while the net profit after deducting non-recurring gains and losses was 39.79 million yuan, up 75.19%[21] Cash Flow and Assets - The net cash flow from operating activities was ¥11,705,969.12, down 33.80% from ¥17,682,461.62 in the same period last year[19] - The total assets at the end of the reporting period were ¥887,429,447.79, an increase of 2.77% compared to ¥863,547,635.75 at the end of the previous year[19] - The net assets attributable to shareholders of the listed company decreased by 0.94% to ¥809,025,460.60 from ¥816,700,677.15 at the end of the previous year[19] - The company's cash and cash equivalents as of June 30, 2021, amounted to RMB 1,335,121,970.09, a decrease from RMB 340,060,690.70 at the end of 2020[181] - The total current assets decreased to RMB 648,713,708.59 from RMB 677,790,269.80 at the end of 2020[181] - The company's inventory increased to RMB 128,065,288.70 from RMB 100,940,279.71 at the end of 2020, indicating a growth of approximately 26.7%[181] Research and Development - R&D expenses amounted to 9.10 million yuan, increasing by 22.54% from 7.43 million yuan in the previous year, although the proportion of R&D expenses to operating revenue decreased by 1.13 percentage points[21] - The company has applied for a total of 180 patents and obtained 116 patents as of June 30, 2021[47] - Research and development expenses increased to ¥9,104,537.74, up 22.6% from ¥7,429,834.17 in the first half of 2020[189] - The company has developed a range of products under the "Aladdin" brand, covering high-end chemicals, life sciences, analytical chromatography, and materials science[36] - The company emphasizes continuous R&D investment and technological upgrades to meet diverse user needs and adapt to market trends[33] Market Position and Strategy - The company is focusing on expanding its product range and enhancing its market presence in the scientific service industry, which is crucial for technological innovation[26] - The domestic scientific reagent industry is transitioning from informal operations to standardized practices, with opportunities for companies with strong technical capabilities to grow rapidly[28] - The company has over 35,000 types of research reagents in stock and has been recognized as one of the most comprehensive manufacturers in the domestic market[30] - The company has been awarded the title of "Most Popular Reagent Brand" for nine consecutive years and ranked among the "Top Ten Enterprises in China's Chemical Reagent Industry" for six years[30] - The company has established an e-commerce platform to enhance sales efficiency and customer experience, adapting to the characteristics of the scientific service industry[34] Environmental Compliance - The company strictly complies with national environmental protection laws and regulations, ensuring that all production and research operations meet environmental standards[102] - Major pollutants from wastewater include chemical oxygen demand, ammonia nitrogen (NH3-N), pH value, total phosphorus, total nitrogen, and suspended solids, with discharge concentrations meeting pollution discharge standards[103] - The company has implemented pollution control facilities for waste gas, waste water, solid waste, and noise, ensuring compliance with environmental impact assessment requirements[105] - The company has established a wastewater treatment system that separates rainwater and sewage, preventing contamination of the external water environment[105] Shareholder Commitments and Governance - The company has commitments from major shareholders and executives to hold their shares for a minimum of 12 to 36 months post-IPO, ensuring stability in shareholding[109] - The controlling shareholder, Xu Jiuzhen, and related parties have committed to not selling shares for 36 months from the IPO date, which enhances investor confidence[110] - The company has outlined specific reasons for any potential delays in fulfilling these commitments, which adds transparency to its governance practices[109] - The commitments are designed to prevent market volatility and protect the interests of minority shareholders during the initial public offering phase[109] Legal Matters - The company is involved in significant litigation matters, including a lawsuit with Guangzhou Saiyi Information Technology Co., Ltd. regarding a contract dispute, with a total claim amount of approximately RMB 4.3732 million[152] - The company has reached a settlement agreement with Guangzhou Saiyi, agreeing to pay RMB 830,000 to resolve the litigation, which will not have a significant adverse impact on its operations[154] - There are no major violations or penalties involving the company or its executives during the reporting period[155]

Financial Performance - Net profit attributable to shareholders rose by 146.66% to CNY 20,036,519.25 year-on-year[6] - Operating revenue increased by 76.10% to CNY 62,717,903.12 compared to the same period last year[6] - Basic earnings per share increased by 81.82% to CNY 0.20[6] - Operating profit for Q1 2021 was ¥26,241,332.39, up 180.8% from ¥9,333,843.13 in Q1 2020[25] - Net profit for Q1 2021 was ¥20,036,519.25, representing a 147.5% increase from ¥8,123,294.49 in Q1 2020[25] Cash Flow - The net cash flow from operating activities improved by 80.11%, reaching -CNY 1,669,224.00[6] - Cash inflow from operating activities in Q1 2021 was ¥74,294,075.45, up 82.5% from ¥40,702,519.58 in Q1 2020[29] - The net cash flow from operating activities was ¥60,702.07, a recovery from a net outflow of ¥8,539,086.00 in the same period last year[31] - The company reported a net cash outflow from investing activities of ¥1,192,203.41, compared to a larger outflow of ¥2,198,887.65 in Q1 2020, indicating improved investment management[31] Assets and Liabilities - Total assets increased by 2.48% to CNY 884,962,606.98 compared to the end of the previous year[6] - Current assets totaled CNY 679,347,930.25, slightly up from CNY 677,790,269.80, indicating a marginal increase of about 0.2%[19] - Non-current assets rose to CNY 205,614,676.73 from CNY 185,757,365.95, representing an increase of approximately 10.7%[19] - Total liabilities amounted to CNY 47,329,794.88, a slight increase from CNY 46,846,958.60, showing a growth of about 1.0%[20] - The company's total liabilities decreased by 40.26% in contract liabilities, down to RMB 908,805.77, due to the completion of custom sales contracts[15] Shareholder Information - The total number of shareholders reached 4,968 by the end of the reporting period[11] - The top ten shareholders hold a combined 73.74% of the company's shares, with the largest shareholder owning 27.74%[12] Research and Development - Research and development expenses accounted for 6.36% of operating revenue, a decrease of 2.92 percentage points from the previous year[6] - Research and development expenses for Q1 2021 totaled ¥3,991,147.69, an increase of 20.8% from ¥3,305,670.02 in Q1 2020[24] Other Financial Metrics - The weighted average return on equity increased by 0.1 percentage points to 2.42%[6] - The company's investment income for the quarter was RMB 538,301.37, reflecting returns from cash management investments[15] - The company's credit impairment losses rose by 922.30% to RMB -409,348.61, as the company made provisions for bad debts[15] - The company's financial expenses saw a dramatic increase of 1444.40%, resulting in RMB -1,895,661.90, attributed to interest income from cash management[15]

Financial Performance - The company's operating revenue for 2020 was ¥234.22 million, an increase of 11.74% compared to ¥209.60 million in 2019[21]. - Net profit attributable to shareholders was ¥74.43 million, reflecting a growth of 16.86% from ¥63.69 million in the previous year[21]. - The net profit after deducting non-recurring gains and losses was ¥69.91 million, up 9.43% from ¥63.88 million in 2019[21]. - Cash flow from operating activities increased significantly by 44.85% to ¥81.39 million, compared to ¥56.19 million in 2019[21]. - Total assets grew by 121.09% to ¥863.55 million, primarily due to the net proceeds of ¥434.43 million from the initial public offering on the Sci-Tech Innovation Board[22]. - Net assets attributable to shareholders increased by 135.92% to ¥816.70 million, driven by the IPO and growth in retained earnings[23]. - Basic earnings per share rose to ¥0.93, a 10.71% increase from ¥0.84 in 2019[22]. - The company achieved a total revenue of 234,220,217.66 RMB, representing an increase of 11.74% year-on-year[74]. - The net profit for the period was 74,432,146.09 RMB, reflecting a year-on-year growth of 16.86%[74]. Dividend Policy - The company plans to distribute a cash dividend of 5.00 RMB per 10 shares, totaling 50,466,700.00 RMB, which accounts for 67.80% of the net profit attributable to shareholders for 2020[6]. - The cash dividend for 2020 represents 67.80% of the net profit attributable to shareholders of the parent company[127]. - The company aims to enhance its core competitiveness by continuously improving its main product categories and increasing operational efficiency to boost profitability[143]. - The company will prioritize cash dividends in its profit distribution policy to ensure shareholder returns[143]. - The company commits to managing raised funds effectively to enhance profitability and ensure timely project completion to increase shareholder returns[143]. Research and Development - The company applied for a total of 7 patents during the reporting period, including 4 invention patents and 3 utility model patents, with a total of 177 patents applied for and 114 granted cumulatively[53]. - The total R&D investment for the year was approximately ¥15.68 million, representing a decrease of 0.24% compared to the previous year, with R&D investment as a percentage of operating income decreasing from 7.50% to 6.70%[55]. - The company is focusing on the development of high-end specialized reagents, driven by the rapid growth of downstream strategic emerging industries such as biomedicine and new materials[50]. - The company has established its own e-commerce platform to enhance sales efficiency and customer experience, reflecting the ongoing trend of digital transformation in the scientific services industry[51]. - The company’s core technologies cover the entire process from R&D to production of scientific reagents, with some technologies reaching international advanced levels[52]. Market Position and Competition - The company operates in high-end chemicals, life sciences, analytical chromatography, and materials science, with a focus on meeting diverse user needs in various high-tech industries[33]. - The company has been recognized as a "High-tech Enterprise" and a "National Specialized and New Small Giant," reflecting its technological leadership[46]. - The company faces intense competition in the domestic research reagent market, where over 90% of the market share is held by foreign enterprises[80]. - The domestic high-end research reagent market is characterized by a significant supply-demand imbalance, with major international players dominating the market[115]. - The demand for scientific reagents is shifting towards high-purity and specialized reagents, indicating a trend towards more advanced product offerings[49]. Governance and Compliance - The audit report issued by Da Hua Certified Public Accountants confirms the financial report's accuracy and completeness[5]. - The company has no non-operating fund occupation by controlling shareholders or related parties[8]. - The company has no violations in decision-making procedures for external guarantees[8]. - The company has established a quality standard system with over 43,000 product standards developed[66]. - The company has committed to reducing and regulating related party transactions, ensuring compliance with market fairness rules[165]. Operational Risks - The company has detailed various operational risks and corresponding mitigation measures in the report[4]. - The company is at risk of losing core technical personnel if it fails to provide adequate incentives and development opportunities[79]. - The company has a risk of insufficient talent team construction to meet business development needs due to the complexity of its product offerings[79]. - The company's main business revenue is highly concentrated in the East China region, posing a risk if demand decreases in that area[81]. Legal Matters - The company is involved in a legal dispute with Guangzhou Saiyi Information Technology Co., Ltd., claiming a total of 4.3732 million yuan for unpaid contract amounts, interest, and penalties[171]. - The Shanghai Intellectual Property Court ruled on June 9, 2020, to dismiss the company's jurisdictional objection, maintaining the original ruling[172]. - The case has been transferred to the Guangzhou Intellectual Property Court for further handling, and it is currently unresolved[174]. Corporate Social Responsibility - The company has actively participated in social responsibility initiatives by donating various protective materials during the COVID-19 pandemic[198]. - The company is not classified as a key pollutant discharge unit and adheres to environmental protection laws, with no major environmental accidents reported during the reporting period[199].

Financial Performance - Net profit attributable to shareholders rose by 10.63% to CNY 48,202,025.11 for the first nine months of the year[6]. - Basic earnings per share improved by 10.34% to CNY 0.64[7]. - The company reported a total current asset of CNY 220,304,269.47, an increase from CNY 211,869,261.82, reflecting a growth of approximately 3.38%[21]. - Total operating revenue for Q3 2020 reached ¥68,488,159.88, a 31.6% increase from ¥52,018,486.01 in Q3 2019[25]. - Net profit for Q3 2020 was ¥24,012,496.92, representing a 61.2% increase compared to ¥14,891,903.94 in Q3 2019[26]. - The total revenue for the first three quarters of 2020 was CNY 175,156,812.63, compared to CNY 156,166,944.01 in the same period of 2019, indicating a year-over-year increase of 12.1%[32]. Assets and Liabilities - Total assets increased by 2.41% to CNY 400,010,489.88 compared to the end of the previous year[6]. - The company's total current assets as of September 30, 2020, amounted to RMB 215,209,383.55, an increase from RMB 205,388,581.74 at the beginning of the year[17]. - Current liabilities rose to CNY 41,705,394.80, compared to CNY 40,482,030.02, indicating an increase of about 3.02%[18]. - Total liabilities amounted to CNY 45,548,561.68, up from CNY 44,407,196.86, representing an increase of about 2.57%[19]. - Cash and cash equivalents decreased to CNY 67,709,583.81 from CNY 71,730,238.21, a decline of approximately 5.63%[20]. Cash Flow - Operating cash flow increased significantly by 57.27% to CNY 38,651,939.53 year-to-date[6]. - The company's cash flow from operating activities for the year-to-date reached RMB 38,651,939.53, a 57.27% increase compared to RMB 24,576,233.83 in the same period last year, driven by increased sales revenue[15]. - The net cash flow from operating activities for the first three quarters of 2020 was CNY 38,651,939.53, compared to CNY 24,576,233.83 in the same period of 2019, an increase of 57.3%[32]. - The cash outflow from investing activities for the first three quarters of 2020 was CNY 6,430,845.91, compared to CNY 4,236,230.37 in the same period of 2019, reflecting an increase of 52.0%[33]. Shareholder Information - The total number of shareholders reached 282 by the end of the reporting period[12]. - The largest shareholder, Xu Jiuzhen, holds 36.99% of the shares, totaling 28,000,000 shares[12]. Research and Development - R&D expenditure accounted for 6.94% of total revenue, down from 8.51% in the previous year[7]. - Research and development expenses for Q3 2020 totaled ¥3,667,595.28, a decrease of 28.1% from ¥5,104,062.77 in Q3 2019[25]. Government Support - The company received government subsidies amounting to CNY 2,984,861.95 year-to-date, contributing to its financial performance[9]. - The company received other income of RMB 2,984,861.95, a 704.85% increase from RMB 370,859.96, mainly from various subsidies[14]. Future Outlook - The company plans to continue its market expansion and product development initiatives, although specific figures were not disclosed in the report[15]. - The company did not provide specific guidance for future performance in the conference call[45].